Minimizing liver uptake of cationic 99mTc radiotracers with ether and crown ether functional groups

doi:10.4254/wjh.v2.i1.21

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4467)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

291

HTML

3907

Figures (1-9)

269

Sum=4467

Jan 27, 2010 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jan 27, 2010; 2(1): 21-31
Published online Jan 27, 2010. doi: 10.4254/wjh.v2.i1.21

Full Size Figure Download Figure

Figure 1 ^99mTc radiotracers useful for heart imaging. ^99mTc-Sestamibi, ^99mTc-Tetrofosmin and ^99mTc-Teboroxime have been approved as commercial radiopharmaceuticals for myocardial perfusion imaging.

Citation: Kim YS, Wang F, Liu S. Minimizing liver uptake of cationic ^99mTc radiotracers with ether and crown ether functional groups. World J Hepatol 2010; 2(1): 21-31
URL: https://www.wjgnet.com/1948-5182/full/v2/i1/21.htm
DOI: https://dx.doi.org/10.4254/wjh.v2.i1.21